[Ip-health] Press links on OTA and lack of Bayh-Dole safeguards in COVID-contracts

Claire Cassedy claire.cassedy at keionline.org
Thu Jul 2 08:31:35 PDT 2020

Below are links to some of the press coverage on the Other Transaction
Authority agreement issue and the COVID-related OTAs.

Christopher Rowland. "Trump administration makes it easier for drugmakers
to profit from publicly funded coronavirus drugs, advocates say."
Washington Post. July 1, 2020.

Bob Herman. “Federal government weakened its march-in rights for
coronavirus drugs.” Axios. July 1, 2020.

Sharon Lerner. “The Trump Administration is waiving the public’s right to
affordable coronavirus treatments.” The Intercept. July 1, 2020.

Ed Silverman and Nicholas Florko. “Some U.S. government contracts for
Covid-19 research could skirt affordable pricing laws.” STAT. July 1, 2020.

Jonathon Gardner. "Federal coronavirus contracts dodge pricing oversight,
advocacy group says." BioPharma Dive. July 1, 2020.

KEI's press advisory available here:

Claire Cassedy
Knowledge Ecology International
1621 Connecticut Avenue NW
Suite 500
Washington, DC 20009
Tel.: 1.202.332.2670

More information about the Ip-health mailing list